Cloud regulatory information management software for pharmaceutical, MedTech and IVD teams. Covers submission publishing, product registrations, regulatory documents and health-authority correspondence, with links to SmartSolve quality processes.
IQVIA SmartSolve RIM manages regulatory information across products, markets and health authorities. Its modules cover submission planning and publishing, global registrations, regulatory content and authority interactions. Pharmaceutical formats include eCTD and NeeS. Registration records cover approvals, variations, renewals and withdrawals.
Content Management for Pharma is an integral RIM module. It manages document metadata, relationships, versions, renditions, authoring templates and review workflows. IQVIA states that it supports GxP processes and Part 11 electronic records, audit trails and signatures. These are vendor capability claims; each customer remains responsible for validating its configured use.
SmartSolve RIM and SmartSolve eQMS are peer applications on the SmartSolve platform. Quality changes can link to affected global registrations. The suite also connects to IQVIA Regulatory Intelligence. The current module package, add-on charges and ability to license RIM without eQMS require confirmation.
IQVIA dates the current Azure platform launch to Q1 2026. It succeeds the legacy RIM Smart application. Historical customer evidence and the one visible Gartner review predate this release.
Core Capabilities
FDA & GxP Compliance
International Standards
Security Certifications
Data Integrity & Validation
SmartSolve RIM runs in the Microsoft Azure cloud. IQVIA relaunched its legacy RIM application on the SmartSolve platform in Q1 2026. Current tenancy, hosting regions, disaster-recovery objectives, browser requirements and native mobile access are unconfirmed.
The shared suite documents APIs for CRM, ERP, LIMS, MES and PLM integration, with Microsoft Power BI for platform analytics. RIM endpoint coverage, API protocols, authentication, limits and named connectors require confirmation. The platform links quality changes to global registrations. Current SSO protocols and identity providers are unconfirmed.
Deployment & Hosting
IQVIA describes subscription charges based on modules, features and users, with custom quotes and possible service fees. This description appears as vendor-provided information on Gartner Peer Insights. A demo can be requested.
Licence amounts, minimum users, contract terms, free-trial availability and the base RIM module package are unconfirmed. Validation services have separate charging models: Managed Services is paid annually in advance; Extended Validation Services is priced by modules. A current standalone RIM licence without eQMS requires confirmation.
Pricing Model
Subscription
IQVIA offers legacy RIM migration assistance, including data mapping, validation, configuration and training. A deployment timeline by organisation size, named migration tools and the scope included in the base licence are unconfirmed.
SmartSolve Managed Services covers initial PQ script creation, automated PQ execution and upgrade release-note review. Extended Validation Services adds a Validation Manager and formal validation documents. Charges depend on modules and configuration scope. Current RIM module and integration coverage requires confirmation.
PharmaSpotter assessment from published vendor and third-party sources. No user reviews are on file for this product.
Strengths
One Gartner review dated 7 February 2025 praises centralised regulatory information and tracking in legacy RIM Smart. It predates the Q1 2026 platform launch. This single account does not establish satisfaction with the current release.
Limitations & Open Questions
Substantiated user criticism of the current release is unconfirmed. The only visible Gartner review predates the relaunch, and the G2 legacy product listing has no reviews.
Help the community
Share your experience with IQVIA SmartSolve RIM anonymously. Your insights help pharmaceutical professionals make better software decisions.
Contribute Anonymous FeedbackJump to section